Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Cellular Immunology|September 8, 2019
The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myelomaDaniel Feinberg, Barry Paul, Yubin KangJournal of Cancer Metastasis and Treatment|April 26, 2019
Metabolic alterations and the potential for targeting metabolic pathways in the treatment of multiple myelomaDustin Rizzieri, Barry Paul, Yubin KangPlos One|July 7, 2015
Didymosphenia geminata in the Upper Esopus Creek: Current Status, Variability, and Controlling FactorsScott Daniel George, Barry Paul BaldigoDrugs|April 12, 2022
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma TherapyBarry Paul, Cesar Rodriguez, Saad Z UsmaniCancers|November 11, 2022
Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple MyelomaJian Wu, Emily Chu, Barry Paul, et al.Immunotherapy|May 21, 2016
Checkpoint inhibition for colorectal cancer: progress and possibilitiesBarry Paul, Bert H O'Neil, Autumn J McReeCellular Immunology|October 22, 2018
The challenges of checkpoint inhibition in the treatment of multiple myelomaBarry Paul, Shuqi Kang, Zhihong Zheng, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Induction Therapy for Newly Diagnosed Multiple MyelomaBarry Paul, Brea Lipe, Enrique M Ocio, et al.The Journal of Cell Biology|July 14, 2021
Ist2 recruits the lipid transporters Osh6/7 to ER-PM contacts to maintain phospholipid metabolismAndrew King On Wong, Barry Paul Young, Christopher J R LoewenLeukemia & Lymphoma|July 7, 2020
Management of newly diagnosed transplant ineligible multiple myelomaShebli Atrash, Manisha Bhutani, Barry Paul, et al.Pageof 5